VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Conditions:   Colon Carcinoma Metastatic in the Liver;   Colorectal Adenocarcinoma;   Pancreatic Adenocarcinoma;   Resectable Pancreatic Carcinoma;   Stage I Pancreatic Cancer;   Stage IA Pancreatic Cancer;   Stage IB Pancreatic Cancer;   Stage II Pancreatic Cancer;   Stage IIA  Pancreatic Cancer;   Stage IIB Pancreatic Cancer;   Stage III Pancreatic Cancer;   Stage IV Colorectal Cancer;   Stage IVA Colorectal Cancer;   Stage IVB Colorectal Cancer Interventions:   Biological: Anti-SEMA4D Monoclonal Antibody VX15/2503;   Biological: Ipilimumab;   Biological: Nivolumab;   Procedure: Surgery Sponsors:   Emory University;   Vaccinex Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials